Tacedinaline (CI-994), a class I Histone Deacetylase (HDAC) inhibitor was identified in a screen as an apoptosis inducer in MYC-driven cancer cell lines including GBM lines [101]. This evidence concerns the gene HDAC9 and glioblastoma.